Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

WHAT'S NEW

  • Suicide Prevention
  • Hospital Charity Care
  • Hantavirus
  • TrumpRx
  • Pharmacy Discount Coupons

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Oct 7 2025

Full Issue

Viewpoints: Former Surgeons General Warn Of Danger Posed By RFK Jr.; Details Of TrumpRx Are Murky

Opinion writers tackle these public health topics.

The Washington Post: 6 U.S. Surgeons General: RFK Jr. Threatens The Health Of Americans 

As former U.S. surgeons general appointed by every Republican and Democratic president since George H.W. Bush, we have collectively spent decades in service as the Nation’s Doctor. We took two sacred oaths in our lifetimes: first, as physicians who swore to care for our patients and, second, as public servants who committed to protecting the health of all Americans. (Jerome Adams, Richard Carmona, Joycelyn Elders, Vivek Murthy, Antonia Novello, and David Satcher, 10/7)

Bloomberg: White House’s Drug Plan Has Some Convenient Blind Spots

There couldn’t be a more pressing or galvanizing topic for Americans than the high cost of prescription drugs. And after months of blustery talk from President Donald Trump about lowering prices and cracking down on Big Pharma, his plans are finally starting to take shape, beginning with pacts with manufacturers. But before we get too excited, consumers should demand more transparency about what they’re getting from his dealmaking — and ask who is truly benefiting from the sum of his health care actions. (Lisa Jarvis, 10/7)

Stat: Forced Onshoring Of Biosimilar, Generic Manufacturing Threatens Efficiency

Over the past six months, numerous pharmaceutical companies have announced plans to invest in new U.S. manufacturing facilities within the next decade. This so-called “onshoring,” motivated by the Trump administration’s announcement of sector-specific tariffs, seems to make sense on the surface: strengthen domestic manufacturing capabilities and mitigate potential risks of supply disruption. (Gillian Woollett, 10/6)

Stat: What RFK Jr. Gets Wrong About Medical School And Nutrition Education 

One of health secretary Robert F. Kennedy Jr.’s refrains has been that doctors don’t learn enough about nutrition in medical school. In a recent op-ed in The Wall Street Journal, he called for “rigorous, measurable nutrition education at every stage of medical training.” Contrary to what Kennedy might have you believe, medical schools do teach students about nutrition. (Tiffany Onyejiaka, 10/7)

San Francisco Chronicle: President Trump’s War On Gender-Affirming Care Is A Huge Mistake

When I go to the doctor, I expect to be offered treatment options that are most likely to help. You might imagine we all do. But that is changing. Last month, the Trump administration announced a ban on coverage of gender-affirming care for millions of federal employees, which takes effect in 2026. This move follows months of abrupt, politically motivated terminations of research studies that have gutted the science that informs our health care. (Heidi Moseson, 10/6)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF